9.92 -0.25 (-2.46%)
PGNX
| Trade PGNX now with |
|
Stock Details
Last Trade:9.92 Change:-0.25 (-2.46%) Prev Close:10.17 Open: 10.17 Days Range:9.74 – 10.17 52 Week Range: 4.50 - 10.50 Volume:80846 P/E: 248.00EPS:0.04
View AllRecent Alerts 02/09/12
Recent Alert on 01/06/12 at 10:41am
Needham & Company Reiterates a 'Buy' on Progenics Pharmaceuticals (PGNX);
Needham & Company Reiterates a 'Buy' on Progenics Pharmaceuticals (PGNX);
Needham & Company reiterates a 'Buy' on Progenics Pharmaceuticals (NASDAQ: PGNX) price target of $10.00. Needham analyst says, "Progenics and collaborator Salix announced in December 2011 that a Phase 3 trial of oral Relistor met primary and... Read More
Recent Alert on 12/20/11 at 2:55pm
Unusual 11 Mid-Day Movers 12/20: (CIE) (CSIQ) (PGNX) (NED) Higher; (TRGT) (SBLK) (RHT) Lower
Unusual 11 Mid-Day Movers 12/20: (CIE) (CSIQ) (PGNX) (NED) Higher; (TRGT) (SBLK) (RHT) Lower
Recent Alert on 12/20/11 at 1:32pm
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Relistor News Provides Upside To Our Estimates
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Relistor News Provides Upside To Our Estimates
Recent Alert on 12/20/11 at 11:22am
Morning Movers 12/20: (CSIQ) (CIE) (PBH) (DBLE) Higher; (TRGT) (RHT) Lower
Morning Movers 12/20: (CSIQ) (CIE) (PBH) (DBLE) Higher; (TRGT) (RHT) Lower
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 1:30pm
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/